These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33061856)

  • 1. LOXL1-AS1 contributes to the proliferation and migration of laryngocarcinoma cells through miR-589-5p/TRAF6 axis.
    He G; Yao W; Li L; Wu Y; Feng G; Chen L
    Cancer Cell Int; 2020; 20():504. PubMed ID: 33061856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
    Zhang P; Zhao F; Jia K; Liu X
    Bioengineered; 2022 Feb; 13(2):2567-2584. PubMed ID: 35015607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Non-coding RNA LOXL1-AS1 Facilitates Colorectal Cancer Progression via Regulating miR-1224-5p/miR-761/HK2 Axis.
    Guo T; Peng S; Liu D; Li Y
    Biochem Genet; 2022 Dec; 60(6):2416-2433. PubMed ID: 35441953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-conding RNA LOXL1-AS1 sponges miR-589-5p to up-regulate CBX5 expression in renal cell carcinoma.
    Wu C; Zhang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Non-Coding RNA LOXL1-AS1 Enhances Colorectal Cancer Proliferation, Migration and Invasion Through miR-708-5p/CD44-EGFR Axis.
    Wu X; Cui F; Chen Y; Zhu Y; Liu F
    Onco Targets Ther; 2020; 13():7615-7627. PubMed ID: 32821123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LOXL1-AS1 facilitates the tumorigenesis and stemness of gastric carcinoma via regulation of miR-708-5p/USF1 pathway.
    Sun Q; Li J; Li F; Li H; Bei S; Zhang X; Feng L
    Cell Prolif; 2019 Nov; 52(6):e12687. PubMed ID: 31468594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells.
    Bai T; Liu Y; Li B
    IUBMB Life; 2019 Oct; 71(10):1537-1551. PubMed ID: 31188543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LOXL1-AS1 Drives The Progression Of Gastric Cancer Via Regulating miR-142-5p/PIK3CA Axis.
    Li M; Cai O; Tan S
    Onco Targets Ther; 2019; 12():11345-11357. PubMed ID: 31908498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LOXL1-AS1 promotes endometrial cancer progression by sponging miR-28-5p to upregulate RAP1B expression.
    Yang X; Xing G; Liu S; Li B; He Y; Wang F
    Biomed Pharmacother; 2020 May; 125():109839. PubMed ID: 32006897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted-regulating of miR-515-5p by LncRNA LOXL1-AS1 on the proliferation and migration of trophoblast cells.
    Zhang L; Wan Q; Zhou H
    Exp Mol Pathol; 2021 Feb; 118():104588. PubMed ID: 33278425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NCK1-AS1 promotes the progression of melanoma by accelerating cell proliferation and migration via targeting miR-526b-5p/ADAM15 axis.
    Lin Q; Jia Y; Zhang D; Jin H
    Cancer Cell Int; 2021 Jul; 21(1):367. PubMed ID: 34247598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA LOXL1-AS1/miR-28-5p/SEMA7A axis facilitates pancreatic cancer progression.
    Liu Y; Guo C; Li F; Wu L
    Cell Biochem Funct; 2020 Jan; 38(1):58-65. PubMed ID: 31732974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-coding RNA LOXL1-AS1 exhibits oncogenic activity in ovarian cancer via regulation of miR-18b-5p/VMA21 axis.
    Xue F; Xu YH; Shen CC; Qin ZL; Zhou HB
    Biomed Pharmacother; 2020 May; 125():109568. PubMed ID: 32058209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA LOXL1-AS1 promotes liver cancer cell proliferation and migration by regulating the miR-377-3p/NFIB axis.
    Yu W; Dai Y
    Oncol Lett; 2021 Aug; 22(2):624. PubMed ID: 34267816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
    Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
    Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOXL1-AS1 communicating with TIAR modulates vasculogenic mimicry in glioma via regulation of the miR-374b-5p/MMP14 axis.
    Yi B; Li H; Cai H; Lou X; Yu M; Li Z
    J Cell Mol Med; 2022 Jan; 26(2):475-490. PubMed ID: 34890108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of LOXL1-AS1 alleviates oxidative low-density lipoprotein induced angiogenesis via downregulation of miR-590-5p mediated KLF6/VEGF signaling pathway.
    Cheng X; Liu Z; Zhang H; Lian Y
    Cell Cycle; 2021 Sep; 20(17):1663-1680. PubMed ID: 34334119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA LOXL1-AS1 is transcriptionally activated by JUND and contributes to osteoarthritis progression via targeting the miR-423-5p/KDM5C axis.
    Chen K; Fang H; Xu N
    Life Sci; 2020 Oct; 258():118095. PubMed ID: 32679142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LOXL1-AS1 controls osteogenic and adipocytic differentiation of bone marrow mesenchymal stem cells in postmenopausal osteoporosis through regulating the miR-196a-5p/Hmga2 axis.
    Zhang L; Xie H; Li S
    J Bone Miner Metab; 2020 Nov; 38(6):794-805. PubMed ID: 32651705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOXL1-AS1 promotes cell proliferation in hepatocellular carcinomathrough miR-1224-5p/ITPRIPL2/AKT axis.
    Chen T; Zeng S; Liu Q; Chen Y; Lu J
    Cell Mol Biol (Noisy-le-grand); 2023 Jul; 69(7):45-50. PubMed ID: 37715432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.